Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock

Journal of Critical Care

Volumn 25, Issue 2, 2010, Pages 276-281

  Artero, Arturo ^a   Zaragoza, Rafael ^a   Camarena, Juan J ^a   Sancho, Susana ^a   González, Rosa ^a   Nogueira, José M ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Bacteremia; Inadequate empirical antimicrobial treatment; Intensive care unit; Mortality; Sepsis syndrome; Septic shock

Indexed keywords

ALBUMIN;

ADULT; ALCOHOLISM; APACHE; ARTICLE; BLOODSTREAM INFECTION; CANDIDA GLABRATA; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DIABETES MELLITUS; ESCHERICHIA COLI; FEMALE; HEART FAILURE; HUMAN; HYPOALBUMINEMIA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; NEOPLASM; PROGNOSIS; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SEPSIS; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIA; TERTIARY HEALTH CARE;

ACADEMIC MEDICAL CENTERS; AGED; ALBUMINS; ANTI-BACTERIAL AGENTS; APACHE; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; SPAIN;

EID: 77953289388     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2009.12.004     Document Type: Article

References (31)

1. Annane D., Bellissant E., Cavaillon J.M. Septic shock. Lancet 2005, 365:63-78.
2. Annane D., Aegerter P., Jars-Guincestre M.C., et al. Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med 2003, 1687:165-172.
3. Cunha B.A. Sepsis and septic shock: selection of empiric antimicrobial therapy. Crit Care Clin 2008, 24:313-314.
4. Rangel-Frausto M.S., Pittet D., Costigan M., et al. The natural history of the systemic inflammatory response syndrome (SIRS). JAMA 1995, 273:117-123.
5. Martin G.S., Mannino D.M., Eaton S., et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554.
6. Crowe M., Ispahani P., Humphreys H., et al. Bacteremia in the adult intensive care unit of a teaching hospital in Nottingham, UK, 1985-1996. Eur J Clin Microbiol Infect Dis 1998, 17:377-384.
7. Ibrahim E.H., Sherman G., Ward S., et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000, 118:146-155.
8. Zaragoza R., Artero A., Camarena J.J., et al. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect 2003, 9:1-7.
9. Hugonnet S., Harbarth S., Ferrière K., et al. Bacteremic sepsis in intensive care: temporal trends in incidence, organ dysfunction, and prognosis. Crit Care Med 2003, 31:390-394.
10. Dellinger R.P., Carlet J.M., Masur H., et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004, 30:536-555.
11. Ferrer R., Artigas A., Levy M.M., et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008, 299:2294-2303.
12. Talan D.A., Moran G.J., Abrahamian F.M. Severe sepsis and septic shock in the emergency department. Infect Dis Clin North Am 2008, 22:1-31.
13. Vallés J., Rello J., Ochagavía A., et al. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest 2003, 123:1615-1624.
14. Kollef M.H., Sherman G., Ward S., et al. Inadequate antimicrobial treatment of infections. A risk factor of hospital mortality among critically ill patients. Chest 1999, 115:462-474.
15. Garnacho-Montero J., Ortiz-Leyva C., Herrera-Melero I., et al. Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study. J Antimicrob Chemother 2008, 61:436-441.
16. Leibovici L., Shraga I., Drucker M., et al. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998, 244:379-386.
17. Kollef M.H., Sherman G., Ward S., et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999, 115:462-474.
18. Garnacho-Montero J., Garcia-Garmendia J.L., Barrero-Almodovar A., et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003, 31:2742-2751.
19. Definition for sepsis and organ failures and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101:1644-1655. American College of Chest Physicians/Society of Critical Care Medicine Consensus Committee.
20. McCabe W.R., Jackson G.G. Gram negative bacteremia. Arch Intern Med 1962, 110:92-100.
21. Laupland K.B., Gregson D.B., Zygun D.A., et al. Severe bloodstream infections: a population-based assessment. Crit Care Med 2004, 32:992-997.
22. Bone R.C., Fisher C.J., Clemmer T.P., et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987, 317:653-658.
23. Rello J., Ricart M., Mirelis B., et al. Nosocomial bacteremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes. Intensive Care Med 1994, 20:94-98.
24. Pittet D., Thievent B., Wenzel R.P., et al. Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. Am J Respir Crit Care Med 1996, 153:684-693.
25. Vallés J., León C., Alvarez-Lerma F. Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Española de Medicina Intensiva y Unidades Coronarias (SEMIUC). Clin Infect Dis 1997, 24:387-395.
26. Wallace S.M., Walton B.I., Kharbanda R.K., et al. Mortality from infective endocarditis: clinical predictors of outcome. Heart 2002, 88:53-60.
27. Goldwasser P., Feldman J. Association of serum albumin and mortality risk. J Clin Epidedemiol 1997, 50:693-703.
28. Beck D.H., Taylor B.L., Millar B., et al. Prediction of outcome from intensive care: a prospective cohort study comparing Acute Physiology and Chronic Health Evaluation II and III prognostic systems in a United Kingdom intensive care unit. Crit Care Med 1997, 25:9-15.
29. Friedman N.D., Kaye K.S., Stout J.E., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137:791-797.
30. Kumar A., Roberts D., Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596.
31. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.